amsbio MagSi STA

AMSBIO expands range of high performance magnetic beads for immunoassays

AMSBIO has expanded its range of high-performance magnetic beads for use as detection labels in magnetic immunoassays or as a solid support phase in immunoassays.  

Biotech degasser 1

Biotech Fluidics launches two degassers optimised for nanofluidic systems

Biotech Fluidics has introduced two new additions to their popular DEGASi family of high-performance in-line degassers. The DEGASi Plus Nano and DEGASi Plus ultraNano have been design optimised to address the challenge of nanofluidic systems by minimizing the hold-up volume and offering wide chemical compatibility.

DeepMirror team

DeepMirror launches Early Access Programme for its intuitive molecular drug design software

DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, launched its Early Access Programme on 11 December 2023 after a successful closed beta programme during which chemists were invited to test the software over several months. The software allows users to tap into AI-driven insights to […]

shutterstock 2180750039

Biotium launches new line of primary antibody conjugates for flow cytometry

Biotium has launched Biotium Choice primary antibody conjugates. With careful curation and extensive in-house validation, Biotium Choice monoclonal primary antibodies are designed to deliver exceptional performance for flow cytometry.

Azenta color PCR plates

Azenta’s new coloured PCR plates improve visual identification in multi-user labs

Azenta Life Sciences popular FrameStar 96-well Skirted PCR plate is now available in a wide range of colours (purple, blue, clear, green, red, black, and white) to enable easy visual identification in multi-user labs. Whether you work in a busy pathology, molecular diagnostics, or academic lab, assigning different coloured PCR plates can be a real […]

shutterstock 1902146578

PrecisionLife project awarded Innovate UK Grant to improve diagnosis and treatment of ME/CFS and long Covid

Leading computational biology company PrecisionLife, which is driving precision medicine in complex chronic diseases, the ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh, have been awarded a £622,000 (about US$794,000) grant by Innovate UK’s Advancing Precision Medicine programme […]

shutterstock 1496330648

ANTABIO raises €25 million for phase 2 next-gen antibacterial study

Antabio SAS, a clinical stage biopharmaceutical company developing novel treatments for severe drug-resistant bacterial infections, has raised €25 million in a Series B financing round, which will enable the company to complete the phase 2 clinical studies of MEM-ANT3310, a next generation antibacterial.

shutterstock 530971462

Metrion Biosciences closes £3.5m new equity financing to expand Cambridge laboratories

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, has secured £3.5 million (about US$3,19 million) in new equity financing, including £2.5m from lead investor Maven Capital Partners and £1 million from existing investor, Gresham House Ventures. The funding will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist […]

shutterstock 1726134715

Aptamer Group signs agreement with biotech company to develop Optimer binders for genetic medicines

Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has entered into a material agreement with a biotechnology company developing genetic medicines.

Scherm­afbeelding 2024 01 17 om 15.06.08

ProBioGen granted patent for DirectedLuck transposase technology

ProBioGen’s Transposase binds to specific epigenetic histone marks characteristic for highly active genome regions. Omitting the plasmid backbone, multiple transposable elements carrying the transgene cassette are specifically inserted resulting in highly stable and high expressing clones.